Works by Fujimoto, Kiyohide


Results: 312
    1
    2
    3

    The effects of chlormadinone acetate on lower urinary tract symptoms and erectile functions of patients with benign prostatic hyperplasia: a prospective multicenter clinical study.

    Published in:
    2013
    By:
    • Kiyohide Fujimoto;
    • Yoshihiko Hirao;
    • Yasuo Ohashi;
    • Yasuhiro Shibata;
    • Kohzo Fuji;
    • Hidenori Tsuji;
    • Katsuhito Miyazawa;
    • Mikinobu Ohtani;
    • Ryoji Furuya;
    • Eitetsu Boku;
    • Fujimoto, Kiyohide;
    • Hirao, Yoshihiko;
    • Ohashi, Yasuo;
    • Shibata, Yasuhiro;
    • Fuji, Kohzo;
    • Tsuji, Hidenori;
    • Miyazawa, Katsuhito;
    • Ohtani, Mikinobu;
    • Furuya, Ryoji;
    • Boku, Eitetsu
    Publication type:
    journal article
    4

    Transperineal template-guided saturation biopsy aimed at sampling one core for each milliliter of prostate volume: 103 cases requiring repeat prostate biopsy.

    Published in:
    2017
    By:
    • Yasushi Nakai;
    • Nobumichi Tanaka;
    • Satoshi Anai;
    • Makito Miyake;
    • Shunta Hori;
    • Yoshihiro Tatsumi;
    • Tomomi Fujii;
    • Noboru Konishi;
    • Kiyohide Fujimoto;
    • Nakai, Yasushi;
    • Tanaka, Nobumichi;
    • Anai, Satoshi;
    • Miyake, Makito;
    • Hori, Shunta;
    • Tatsumi, Yoshihiro;
    • Morizawa, Yosuke;
    • Fujii, Tomomi;
    • Konishi, Noboru;
    • Fujimoto, Kiyohide
    Publication type:
    journal article
    5
    6
    7
    8
    9
    10
    11
    12
    13

    The impact of second transurethral resection on survival outcomes in patients with non-muscle-invasive bladder cancer treated with bacillus Calmette–Guérin therapy.

    Published in:
    Japanese Journal of Clinical Oncology, 2024, v. 54, n. 2, p. 192, doi. 10.1093/jjco/hyad155
    By:
    • Kikuchi, Hiroshi;
    • Abe, Takashige;
    • Miyake, Makito;
    • Miyata, Haruka;
    • Matsumoto, Ryuji;
    • Osawa, Takahiro;
    • Nishimura, Nobutaka;
    • Fujimoto, Kiyohide;
    • Inokuchi, Junichi;
    • Yoneyama, Takahiro;
    • Tomida, Ryotaro;
    • Numakura, Kazuyuki;
    • Matsushita, Yuto;
    • Matsumoto, Kazumasa;
    • Sato, Takuma;
    • Taoka, Rikiya;
    • Kobayashi, Takashi;
    • Kojima, Takahiro;
    • Matsui, Yoshiyuki;
    • Nishiyama, Naotaka
    Publication type:
    Article
    14

    Clinical practice of UroVysion® urine test in patients with bladder carcinoma in situ treated with intravesical Bacillus Calmette–Guerin.

    Published in:
    Japanese Journal of Clinical Oncology, 2023, v. 53, n. 7, p. 629, doi. 10.1093/jjco/hyad029
    By:
    • Miyake, Makito;
    • Hori, Shunta;
    • Fujii, Tomomi;
    • Nishimura, Nobutaka;
    • Oda, Yuki;
    • Miyamoto, Tatsuki;
    • Tomizawa, Mitsuru;
    • Shimizu, Takuto;
    • Ohnishi, Kenta;
    • Morizawa, Yosuke;
    • Gotoh, Daisuke;
    • Nakai, Yasushi;
    • Torimoto, Kazumasa;
    • Tanaka, Nobumichi;
    • Fujimoto, Kiyohide
    Publication type:
    Article
    15

    The Japanese health care system-based cost-effectiveness of photodynamic diagnosis-assisted transurethral resection of bladder tumor for non-muscle invasive bladder cancer.

    Published in:
    Japanese Journal of Clinical Oncology, 2023, v. 53, n. 4, p. 343, doi. 10.1093/jjco/hyac203
    By:
    • Nishimura, Nobutaka;
    • Miyake, Makito;
    • Miyamoto, Tatsuki;
    • Tomizawa, Mitsuru;
    • Shimizu, Takuto;
    • Morizawa, Yosuke;
    • Hori, Shunta;
    • Gotoh, Daisuke;
    • Nakai, Yasushi;
    • Torimoto, Kazumasa;
    • Tanaka, Nobumichi;
    • Fujimoto, Kiyohide
    Publication type:
    Article
    16

    Switch-maintenance avelumab immunotherapy following first-line chemotherapy for patients with advanced, unresectable or metastatic urothelial carcinoma: the first Japanese real-world evidence from a multicenter study.

    Published in:
    Japanese Journal of Clinical Oncology, 2023, v. 53, n. 3, p. 253, doi. 10.1093/jjco/hyac186
    By:
    • Miyake, Makito;
    • Shimizu, Takuto;
    • Oda, Yuki;
    • Tachibana, Akira;
    • Ohmori, Chihiro;
    • Itami, Yoshitaka;
    • Kiba, Keisuke;
    • Tomioka, Atsushi;
    • Yamamoto, Hiroaki;
    • Ohnishi, Kenta;
    • Nishimura, Nobutaka;
    • Hori, Shunta;
    • Morizawa, Yosuke;
    • Gotoh, Daisuke;
    • Nakai, Yasushi;
    • Torimoto, Kazumasa;
    • Fujii, Tomomi;
    • Tanaka, Nobumichi;
    • Fujimoto, Kiyohide
    Publication type:
    Article
    17

    Prostate-specific antigen bounce after <sup>125</sup>I-brachytherapy for prostate cancer is a favorable prognosticator in patients who are biochemical recurrence-free at 4 years and correlates with testosterone.

    Published in:
    Japanese Journal of Clinical Oncology, 2020, v. 50, n. 1, p. 58, doi. 10.1093/jjco/hyz136
    By:
    • Nakai, Yasushi;
    • Tanaka, Nobumichi;
    • Asakawa, Isao;
    • Anai, Satoshi;
    • Miyake, Makito;
    • Morizawa, Yosuke;
    • Hori, Shunta;
    • Owari, Takuya;
    • Fujii, Tomomi;
    • Yamaki, Kaori;
    • Hasegawa, Masatoshi;
    • Fujimoto, Kiyohide
    Publication type:
    Article
    18

    Efficacy and safety of sequential use of everolimus in Japanese patients with advanced renal cell carcinoma after failure of first-line treatment with vascular endothelial growth factor receptor tyrosine kinase inhibitor: a multicenter phase II clinical trial

    Published in:
    Japanese Journal of Clinical Oncology, 2017, v. 47, n. 6, p. 551, doi. 10.1093/jjco/hyw194
    By:
    • Masafumi Oyama;
    • Takayuki Sugiyama;
    • Masahiro Nozawa;
    • Kiyohide Fujimoto;
    • Takeshi Kishida;
    • Go Kimura;
    • Noriaki Tokuda;
    • Shiro Hinotsu;
    • Kojiro Shimozuma;
    • Hideyuki Akaza;
    • Seiichiro Ozono
    Publication type:
    Article
    19
    20

    Changes in oncological outcomes after radical nephroureterectomy in patients with upper urinary tract urothelial carcinoma treated in the last two decades: a retrospective analysis based on a multicenter collaborative study.

    Published in:
    Japanese Journal of Clinical Oncology, 2016, v. 46, n. 12, p. 1148, doi. 10.1093/jjco/hyw128
    By:
    • Makito Miyake;
    • Yoshihiro Tatsumi;
    • Kiyohide Fujimoto;
    • Kazuhiro Nagao;
    • Shigeru Sakano;
    • Hideyasu Matsuyama;
    • Teruo Inamoto;
    • Haruhito Azuma;
    • Hiroaki Yasumoto;
    • Hiroaki Shiina
    Publication type:
    Article
    21
    22
    23
    24
    25

    Treated Natural History of Superficial BladderCancer.

    Published in:
    Japanese Journal of Clinical Oncology, 2001, v. 31, n. 11, p. 536, doi. 10.1093/jjco/hye114
    By:
    • Ozono, Seiichiro;
    • Hinotsu, Shiro;
    • Tabata, Shoichi;
    • Takashima, Kenji;
    • Fujimoto, Kiyohide;
    • Okajima, Eigoro;
    • Hirao, Yoshihiko;
    • Ohashi, Yasuo;
    • Akaza, Hideyuki;
    • Fukushima, Shoji
    Publication type:
    Article
    26
    27
    28

    Impact of Complete Surgical Resection of Metastatic Lesions in Patients with Advanced Renal Cell Carcinoma in the Era of Tyrosine Kinase Inhibitors and Immune Checkpoint Inhibitors.

    Published in:
    Cancers, 2024, v. 16, n. 4, p. 841, doi. 10.3390/cancers16040841
    By:
    • Shimizu, Takuto;
    • Miyake, Makito;
    • Nishimura, Nobutaka;
    • Yoshida, Takanori;
    • Itami, Yoshitaka;
    • Tachibana, Akira;
    • Omori, Chihiro;
    • Oda, Yuki;
    • Kohashi, Mikiko;
    • Tomizawa, Mitsuru;
    • Onishi, Kenta;
    • Hori, Shunta;
    • Morizawa, Yosuke;
    • Dotoh, Daisuke;
    • Nakai, Yasushi;
    • Torimoto, Kazumasa;
    • Tanaka, Nobumichi;
    • Fujimoto, Kiyohide
    Publication type:
    Article
    29

    Efficacy and Safety of First-Line Cytokines versus Sunitinib and Second-Line Axitinib for Patients with Metastatic Renal Cell Carcinoma (ESCAPE Study): A Phase III, Randomized, Sequential Open-Label Study.

    Published in:
    Cancers, 2023, v. 15, n. 10, p. 2745, doi. 10.3390/cancers15102745
    By:
    • Kadono, Yoshifumi;
    • Konaka, Hiroyuki;
    • Nohara, Takahiro;
    • Izumi, Kouji;
    • Anai, Satoshi;
    • Fujimoto, Kiyohide;
    • Koguchi, Tomoyuki;
    • Ishibashi, Kei;
    • Kawai, Noriyasu;
    • Nakane, Keita;
    • Iba, Akinori;
    • Masumori, Naoya;
    • Takahara, Shizuko;
    • Mizokami, Atsushi
    Publication type:
    Article
    30
    31
    32
    33
    34
    35
    36
    37
    38
    39
    40
    41
    42
    43
    44
    45

    Clinical impact of the intensity of follow-up cystoscopy in patients with high-risk non-muscle-invasive bladder cancer.

    Published in:
    International Urology & Nephrology, 2024, v. 56, n. 3, p. 827, doi. 10.1007/s11255-023-03851-3
    By:
    • Miyake, Makito;
    • Nishimura, Nobutaka;
    • Nishioka, Yuichi;
    • Fujii, Tomomi;
    • Oda, Yuki;
    • Miyamoto, Tatsuki;
    • Tomizawa, Mitsuru;
    • Shimizu, Takuto;
    • Owari, Takuya;
    • Ohnishi, Kenta;
    • Hori, Shunta;
    • Morizawa, Yosuke;
    • Gotoh, Daisuke;
    • Nakai, Yasushi;
    • Torimoto, Kazumasa;
    • Tanaka, Nobumichi;
    • Imamura, Tomoaki;
    • Fujimoto, Kiyohide
    Publication type:
    Article
    46

    Clinical utility of bioelectrical impedance analysis in patients with locoregional muscle invasive or metastatic urothelial carcinoma: a subanalysis of changes in body composition during neoadjuvant systemic chemotherapy.

    Published in:
    2018
    By:
    • Miyake, Makito;
    • Owari, Takuya;
    • Iwamoto, Takashi;
    • Morizawa, Yosuke;
    • Hori, Shunta;
    • Iida, Kota;
    • Ohnishi, Kenta;
    • Gotoh, Daisuke;
    • Tatsumi, Yoshihiro;
    • Nakai, Yasushi;
    • Inoue, Takeshi;
    • Anai, Satoshi;
    • Torimoto, Kazumasa;
    • Aoki, Katsuya;
    • Yoneda, Tatsuo;
    • Tanaka, Nobumichi;
    • Fujimoto, Kiyohide;
    • Marugami, Nagaaki;
    • Shimada, Keiji
    Publication type:
    journal article
    47
    48
    49
    50